Organization · Type 2 NPI
Chelsea's Home Living, LLC
Mental Illness Community Based Residential Treatment Facility · Houston, TX
NPI number
1194575100
Active
Practice location
3703 Creekmont Green Ln
Houston, TX 77091-1024
Fax (832) 217-3195
Specialties and licenses
| Taxonomy | Code | License |
|---|---|---|
| Mental Illness Community Based Residential Treatment Facility Primary | 320800000X | None listed |
| Child Intellectual and/or Developmental Disabilities Respite Care | 385HR2060X | None listed |
Mental Illness Community Based Residential Treatment Facility: A home-like residential facility providing psychiatric treatment and psycho/social rehabilitative services to individuals diagnosed with mental illness.
2 other providers at this address
Other mental illness community based residential treatment facility providers in Houston
- Meridian CareMental Illness Community Based Residential Treatment Facility Houston, TX NPI 1073508024
- Mediequip Patient & Home ServicesMental Illness Community Based Residential Treatment Facility Houston, TX NPI 1114392248
- MCR Home Sweet Home LLCMental Illness Community Based Residential Treatment Facility Houston, TX NPI 1134675598
- AwareMental Illness Community Based Residential Treatment Facility Houston, TX NPI 1144471343
- Liberty Island Adult Day CareMental Illness Community Based Residential Treatment Facility Houston, TX NPI 1164693388
- Amtex Care Group LLCMental Illness Community Based Residential Treatment Facility Houston, TX NPI 1184925182
- Ez Living Residential HomeMental Illness Community Based Residential Treatment Facility Houston, TX NPI 1184979114
- Quality Healthcare CenterMental Illness Community Based Residential Treatment Facility Houston, TX NPI 1194973297
About NPI 1194575100
Chelsea's Home Living, LLC's National Provider Identifier is 1194575100, issued on Mar 25, 2024. The primary taxonomy on file is Mental Illness Community Based Residential Treatment Facility (320800000X), and the practice location is in Houston, TX. The record was last updated on Sep 5, 2024.